Clinical trials
Terminated Phase 1 Pancreatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
112 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 12 |
| 2008 | 2 |
| 2009 | 7 |
| 2010 | 4 |
| 2011 | 5 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 7 |
| 2016 | 8 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 9 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 112 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 4 |
| Abramson Cancer Center at Penn Medicine | 3 |
| BioNTech Research & Development, Inc. | 3 |
| National Cancer Institute (NCI) | 3 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 3 |
| University of Texas Southwestern Medical Center | 3 |
| ADC Therapeutics S.A. | 2 |
| Amgen | 2 |
| Boehringer Ingelheim | 2 |
| Duke University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 112 |
| Carcinoma, Non-Small-Cell Lung | 20 |
| Colorectal Neoplasms | 20 |
| Breast Neoplasms | 18 |
| Colonic Neoplasms | 13 |
| Melanoma | 13 |
| Neoplasms | 13 |
| Ovarian Neoplasms | 11 |
| Lung Neoplasms | 10 |
| Stomach Neoplasms | 10 |
Trials
Showing 1 to 25 of 112. Each trial links to its page on Pharma Observatory.
12 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.